Mutations in RAS, particularly in its most frequently altered isoform, KRAS, are strongly associated with a variety of human cancers, establishing RAS as one of the most commonly mutated oncogenes (Burge and Hobbs, 2022). This evidence concerns the gene KRAS and cancer.